Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis

Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis

Show other versions (1)
Bibliographic Details
Main Authors: Andrew R. Moore, Malcolm Boyce, Islay A. Steele, Fiona Campbell, Andrea Varro, D. Mark Pritchard
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815352/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815352/?tool=EBI

Similar Items